EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71,247 | -53.7% | 20,955 | 0.0% | 0.00% | – |
Q2 2023 | $154,019 | -25.6% | 20,955 | +4.9% | 0.00% | – |
Q1 2023 | $206,900 | -15.1% | 19,971 | -3.2% | 0.00% | – |
Q4 2022 | $243,569 | -42.2% | 20,624 | +2.8% | 0.00% | – |
Q3 2022 | $421,143 | -33.6% | 20,064 | -1.9% | 0.00% | – |
Q2 2022 | $634,644 | -94.8% | 20,446 | -93.1% | 0.00% | -100.0% |
Q1 2022 | $12,104,283 | -75.2% | 294,795 | -73.4% | 0.01% | -73.3% |
Q4 2021 | $48,876,000 | -30.3% | 1,107,772 | -20.9% | 0.03% | -47.4% |
Q3 2021 | $70,133,000 | -17.7% | 1,400,682 | +3.6% | 0.06% | -17.4% |
Q2 2021 | $85,199,000 | -23.5% | 1,352,582 | +12.8% | 0.07% | -28.9% |
Q1 2021 | $111,421,000 | +15.0% | 1,199,231 | +10.9% | 0.10% | +9.0% |
Q4 2020 | $96,913,000 | +5.0% | 1,081,617 | +21.1% | 0.09% | -6.3% |
Q3 2020 | $92,319,000 | +26.3% | 893,438 | -7.8% | 0.10% | +37.7% |
Q2 2020 | $73,092,000 | +40.0% | 969,012 | +7.4% | 0.07% | +19.0% |
Q1 2020 | $52,208,000 | +57.3% | 902,317 | +46.7% | 0.06% | +65.7% |
Q4 2019 | $33,192,000 | +30.9% | 615,243 | +23.8% | 0.04% | +25.0% |
Q3 2019 | $25,363,000 | -1.4% | 497,114 | -6.6% | 0.03% | -6.7% |
Q2 2019 | $25,725,000 | +7.4% | 532,490 | +12.3% | 0.03% | +15.4% |
Q1 2019 | $23,959,000 | +1377.1% | 474,247 | +1633.3% | 0.03% | +1200.0% |
Q4 2018 | $1,622,000 | -14.7% | 27,361 | -5.3% | 0.00% | 0.0% |
Q3 2018 | $1,902,000 | +14.0% | 28,905 | -12.5% | 0.00% | 0.0% |
Q2 2018 | $1,668,000 | +24.5% | 33,044 | +29.8% | 0.00% | +100.0% |
Q1 2018 | $1,340,000 | -95.8% | 25,449 | -96.3% | 0.00% | -97.1% |
Q4 2017 | $31,811,000 | +21.1% | 684,537 | +5.4% | 0.03% | +9.7% |
Q3 2017 | $26,262,000 | +22.7% | 649,220 | +2.8% | 0.03% | +19.2% |
Q2 2017 | $21,409,000 | +19.7% | 631,304 | +2.5% | 0.03% | +13.0% |
Q1 2017 | $17,888,000 | -27.1% | 615,990 | -17.6% | 0.02% | -34.3% |
Q4 2016 | $24,550,000 | +19.9% | 747,573 | +15.1% | 0.04% | +16.7% |
Q3 2016 | $20,471,000 | +16.7% | 649,241 | -1.7% | 0.03% | +11.1% |
Q2 2016 | $17,545,000 | -40.1% | 660,656 | -20.5% | 0.03% | +8.0% |
Q1 2016 | $29,279,000 | +16.3% | 831,340 | +32.1% | 0.02% | +4.2% |
Q4 2015 | $25,175,000 | +28.4% | 629,222 | -8.6% | 0.02% | +14.3% |
Q3 2015 | $19,608,000 | +137.6% | 688,262 | +174.7% | 0.02% | +110.0% |
Q2 2015 | $8,254,000 | +47.1% | 250,522 | +28.4% | 0.01% | +42.9% |
Q1 2015 | $5,611,000 | +25.2% | 195,096 | +18.5% | 0.01% | 0.0% |
Q4 2014 | $4,482,000 | -38.2% | 164,597 | -51.6% | 0.01% | -36.4% |
Q3 2014 | $7,247,000 | -11.6% | 340,051 | -6.9% | 0.01% | -8.3% |
Q2 2014 | $8,201,000 | -20.2% | 365,121 | -10.2% | 0.01% | -25.0% |
Q1 2014 | $10,273,000 | +8.1% | 406,509 | -1.6% | 0.02% | +6.7% |
Q4 2013 | $9,499,000 | +22.4% | 413,181 | +1.4% | 0.02% | +15.4% |
Q3 2013 | $7,762,000 | +167.7% | 407,434 | +102.6% | 0.01% | +160.0% |
Q2 2013 | $2,900,000 | – | 201,085 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |